A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Cancer Institute (NCI)
Takeda
Disc Medicine, Inc
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital of Philadelphia
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ossium Health, Inc.
Rigshospitalet, Denmark
Shwachman-Diamond Syndrome Alliance Inc